Company Lexicon Pharmaceuticals, Inc. Nasdaq
Equities
US5288721047
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +766.19% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +766.19% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07/14/07 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 01/99/01 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/21/02 |
Investor Relations Contact | 45 | 13/11 | |
Tom Garner
PRN | Corporate Officer/Principal | - | 09/23/09 |
Wendy Mcdermott
HRO | Human Resources Officer | - | 01/22/01 |
Comptroller/Controller/Auditor | 56 | 01/17/01 | |
General Counsel | - | 04/14/04 | |
Brian Crum
LAW | General Counsel | 51 | 01/01/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 80 | 01/01/01 |
Ray Debbane
CHM | Chairman | 69 | 01/07/01 |
Director/Board Member | 65 | 28/07/28 | |
Philippe Amouyal
BRD | Director/Board Member | 65 | 01/07/01 |
Judith Swain
BRD | Director/Board Member | 75 | 01/07/01 |
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07/14/07 |
Samuel Barker
BRD | Director/Board Member | 81 | 01/00/01 |
Diane Sullivan
BRD | Director/Board Member | 62 | 28/23/28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 247,104,726 | 242,087,491 ( 97.97 %) | 867,973 ( 0.3513 %) | 97.97 % |
Company contact information
Lexicon Pharmaceuticals, Inc.
2445 Technology Forest Boulevard 11th floor
77381-1160, The Woodlands
+
http://www.lexpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-1.07% | 104B | |
+6.68% | 97.47B | |
+5.71% | 22.25B | |
-12.82% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.43% | 16.36B | |
+8.35% | 14.39B | |
+39.87% | 12.37B |